Yearly Archives: 2014


Urapidil Stragen

12/11/2014 C.F.I. Srl has signed an agreement with the Swiss company Stragen Pharma SA for the exclusive distribution of Urapidil Stragen (generic injectable) in Italy. Urapidil is a solution for infusion and is indicated for the treatment of hypertensive emergencies, severe and very severe forms of hypertensive disease, hypertension resistant to treatment.

By |November 12th, 2014|News_CFI|0 Comments